The double marker test, also known as the dual marker test, is a maternal blood screening conducted during the first trimester of pregnancy. This test measures the levels of beta-human Chorionic Gonadotropin (β-hCG), a pregnancy hormone, and Pregnancy-Associated Plasma Protein-A (PAPP-A) in the mother's blood.
Healthcare providers recommend this test, particularly for women over the age of 35, as they have a higher risk of giving birth to a baby with chromosomal abnormalities such as Down's syndrome. The double marker test is often performed alongside the nuchal translucency (NT) scan to confirm the presence of any genetic anomalies.
• Advantages
• Preparation
• When It's Recommended
• Uses
• How It's Performed
• Interpreting Results
• Normal Range
• Cost
• Double Marker vs. Triple Marker Test
• Detection of Trisomy 13: Helps identify trisomy of chromosome 13, which can cause severe birth defects and intellectual disabilities in the infant.
• Detection of Down's Syndrome: Assists in detecting chromosomal abnormalities of chromosome 21, leading to Down's syndrome.
• Assessment of High-Risk Factors: Evaluates potential risks during pregnancy that could be harmful to both the mother and the developing fetus.
• High Detection Rates: Offers reliable detection rates for certain chromosomal abnormalities.
• Informed Decision-Making: A positive result allows couples to consider further diagnostic tests for confirmation or to discuss available options with their healthcare provider.
The test requires a blood sample from the mother and may include an ultrasound scan. Prior to the test:
• Ensure all equipment and machines are properly sterilized and prepared.
• Gather maternal health details such as in vitro fertilization reports, body weight, and diabetic status.
The double marker test is ideal for pregnant women over the age of 35. It is also recommended if there are indications of genetic abnormalities, which can be determined by reviewing the family's medical history or pedigree chart.
• Detecting Down's Syndrome: Identifies the risk of Down's syndrome in the unborn child.
• Assessing Physical Abnormalities: Detects potential issues such as loss of muscle mass, short neck, or excess skin growth at the back of the infant's neck.
• Ensuring Maternal and Fetal Well-being: Evaluates risks of physical features like upward slanting eyes, stunted growth, flattened facial appearance, and severe mental and physical handicaps in newborns.
• Detecting Trisomy 18: Identifies trisomy of chromosome 18, which can lead to clenched fists and deformities of vital organs like the heart, lungs, stomach, and intestines.
• Identifying 'Rocker Bottom Feet': Detects foot deformities where the feet resemble the bottom of a rocking chair.
• Detecting Other Abnormalities: Identifies conditions such as microcephaly (small head), micrognathia (abnormally shaped jaws and mouth), clenched fists, arched spine, and abnormal chest shape.
• Assessing Neurological Development: Detects short sternum and delays in neurological functions of the brain.
• Identifying Umbilical Hernia: Helps distinguish umbilical hernia in the mother during pregnancy.
The test involves a simple blood draw from the pregnant woman. The steps include:
1. Blood Sample Collection: A healthcare professional uses a syringe to draw blood from a vein.
2. Preparation: An elastic band is tied around the upper arm to make the veins more prominent.
3. Cleaning the Site: The area is cleaned with an antiseptic to prevent infection.
4. Needle Insertion: A needle is gently inserted into the vein to collect the blood sample.
5. Sample Preservation: The blood sample is preserved for laboratory testing.
Note: The test poses minimal risks. In rare cases, there may be slight bleeding, formation of a hematoma, bruising, or infection at the needle insertion site.
Results are categorized as either screen positive or screen negative and are presented in the form of ratios. Interpretation depends on:
• The mother's age
• The gestational age of the fetus
• Ultrasound findings during the gestation period
Screen Positive Results:
• Ratios from 1:10 to 1:250 indicate a higher risk of chromosomal abnormalities.
• For example, a ratio of 1:10 means there is a 1 in 10 chance of the fetus developing a genetic disorder, which is significant.
Screen Negative Results:
• Ratios of 1:1000 or higher suggest a lower risk.
• A ratio of 1:1000 indicates a much lower chance of genetic disorders.
If the test results are positive, the doctor may recommend further diagnostic procedures like amniocentesis for confirmation. Couples can then discuss their options with their healthcare provider, considering the potential risks and making informed decisions about the pregnancy.
The triple marker test, conducted between the 15th to 18th week of pregnancy, is used to assess the risk of genetic disorders in the fetus. Also known as the triple test, multiple marker test, or AFP plus, it measures the levels of Alpha-fetoprotein (AFP), Human chorionic gonadotropin (hCG), and estriol in the mother’s blood. This test helps couples understand the health of the developing baby.
Purpose | Procedure | Precautions | Benefits | Interpretation | Preparation | Normal Range | Results | Cost
This test helps identify risk factors in the fetus, such as neural tube defects (spina bifida, anencephaly), and chromosomal abnormalities like Down syndrome (trisomy 21) and trisomy 18 (Edward’s syndrome). It can also detect multiple pregnancies or other congenital conditions in the baby.
The triple marker pregnancy test is straightforward, much like other blood tests, and involves the following steps:
1. The technician will ask you to extend your arm and make a fist to locate the vein.
2. A strap is tied around the arm to secure the area.
3. The technician cleans the area with an antiseptic wipe to prevent any infection.
4. A sterile needle is inserted into the vein, attached to a vial for blood collection.
5. After the vial is filled, the needle is removed, and the area is cleaned again.
6. The collected blood sample is sent to a lab for evaluation.
7. The results are shared with the doctor, who will explain them to the couple.
The procedure is safe, and since only a small amount of blood is drawn, there are no significant risks to the mother or baby.
Couples may opt for an alternative screening test for a second opinion. Prenatal ultrasounds are common alternatives. It’s advisable to consult with a healthcare provider to determine the most suitable tests for an accurate diagnosis.
It’s crucial to provide accurate information to the doctor, as any misguidance may affect test results. Sterilized needles and wipes should be used to avoid introducing blood-borne pathogens, although there are no strict rules for the mother’s preparation.
The test is particularly beneficial for women over 35, who may face increased complications during pregnancy. It helps detect genetic disorders such as trisomy 18 (Edward’s syndrome), Down syndrome, and neural tube defects, allowing parents to prepare in advance for any potential disabilities.
This test is most often recommended for women over 35, couples with a history of congenital disabilities, diabetic mothers, or those who have been exposed to radiation or severe viral infections. The results can help determine if the baby is affected.
The test identifies genetic disorders and abnormalities in the fetus. Several factors influence the results:
• Age of the pregnant woman: As women age, their egg count declines, increasing the risk of genetic disorders.
• Ethnicity: Fertility rates vary across different ethnic groups due to environmental, dietary, and socio-economic factors.
• Body weight: Excessive weight can complicate pregnancies, especially if expecting multiple children.
No special preparation or food restrictions are needed for this test. However, maintaining a healthy diet is essential for the well-being of both mother and baby. Consulting an experienced doctor is always recommended.
Typical marker levels in pregnant women range from 1.38 to 187.00 IU/ml for AFP, 1.06 to 315 ng/ml for hCGβ, and from 0.25 to 28.5 nmol/l for uE3.
The quadruple marker test, also called the quad screen, is a prenatal test used to assess the risk of birth defects in a baby. It screens for conditions like Down syndrome, neural tube defects, trisomy 18 (Edward’s syndrome), and abdominal wall defects. The test involves drawing a blood sample from the mother for analysis, a simple procedure performed by a trained technician called a phlebotomist. No special preparation is needed, and the mother can eat and drink normally before the test. The quad screen is typically performed during the second trimester.
• Purpose
• Procedure
• Risks
• Preparation
• Results
• Cost
This test evaluates the pregnancy for the likelihood of specific conditions such as Down syndrome, neural tube defects, trisomy 18, and abdominal wall defects. If the results suggest the presence of any of these conditions, further screening and testing may be recommended.
The levels of biomarkers tested change as pregnancy progresses, so knowing the pregnancy stage is important before taking the test. Each biomarker is associated with certain fetal abnormalities. For instance, high levels of alpha-fetoprotein (AFP) can indicate neural problems like spina bifida, while low AFP levels may suggest Down syndrome.
Based on the pregnancy timing and symptoms, additional prenatal tests such as an ultrasound or other blood tests may be recommended alongside the quad screen.
The test is performed by a phlebotomist, a technician specialized in drawing blood. Here’s how the process works:
• Pretest: The mother checks in and provides necessary documents such as identification and payment information. Consent forms may also need to be signed to ensure medical confidentiality.
• During the Test: The phlebotomist confirms the mother's identity and asks her to sit comfortably. A tourniquet is applied to the non-dominant arm, and the area is cleaned before inserting the needle to collect blood. The process takes about 20 seconds.
• Post-test: After the blood sample is collected, pressure is applied to stop any bleeding. If bleeding continues, the mother is advised to apply pressure or consult a doctor.
There are generally no physical risks associated with the quadruple test. However, it can cause anxiety for families, and in some cases, test results lead to difficult decisions or emotional stress. There may also be slight bleeding after the blood is drawn, which should be monitored.
No specific physical preparation is required, but emotional preparation is important due to the potential outcomes of the test. Consider the following:
• Timing: Consult with your doctor to determine the best time to take the test.
• Location: Clinics recommended by doctors are the usual places for this test.
• Clothing: Wearing half sleeves can make the blood draw easier. You may want to bring an extra layer if you feel cold after the blood draw.
• Food and Drink: There are no restrictions on eating or drinking before the test.
• What to Bring: It’s advised to eat something beforehand to prevent dizziness, and bringing water or a protein snack is a good idea.
Test results are typically available in about a week. The results include numerical values for the four hormones tested. Your doctor will interpret the results, and you may be able to access them online through your medical records.
• AFP: High AFP levels suggest neural issues like spina bifida; low levels may indicate Down syndrome.
• Estriol: Low estriol levels are associated with Down syndrome, anencephaly, or Edwards syndrome.
• HCG: High levels of HCG may indicate Down syndrome; low levels can suggest anencephaly or Edwards syndrome.
• Inhibin A: Elevated levels of inhibin A are associated with Down syndrome.
High HCG levels may also indicate multiple pregnancies. The quad screen results must be evaluated carefully, as they may overestimate or underestimate risks. Further tests may be needed for a more accurate diagnosis.
Amniocentesis is a procedure where a doctor extracts a small amount of amniotic fluid from a woman's uterus using a long, thin needle. This fluid sample, usually no more than one ounce, is taken during the second trimester of pregnancy. The test is used to assess the baby's lung function and overall health, aiding in decisions regarding pregnancy and delivery.
Purpose | Procedure | Risks and Complications | Alternatives | Preparation | Accuracy | Recovery | Cost
Amniocentesis is typically recommended during the second or third trimester when non-invasive prenatal testing yields abnormal results. It is often suggested for pregnant women over 35 to detect genetic disorders or conditions like Down syndrome and spina bifida. While non-invasive testing is preferable, amniocentesis provides more detailed and accurate results if needed. With 99.9% accuracy, this diagnostic test confirms genetic disorders and can also detect infections in the fetus. It is performed under local anesthesia.
Here's a general outline of the procedure:
1. The patient will undress or wear a hospital gown and lie on an exam table with hands behind the head.
2. Vital signs such as blood pressure, heart rate, and breathing will be checked.
3. An ultrasound is used to locate the baby, placenta, and amniotic fluid pocket while measuring the baby's heart rate.
4. The abdomen is cleaned with antiseptic, and the sterile area should not be touched.
5. A needle is inserted, and a small amount of amniotic fluid is collected using an ultrasound for guidance. The needle passes through the abdominal wall into the uterus and amniotic sac.
6. The sample is stored in a special tube and sent to a lab for analysis.
After the procedure, the baby's heart rate and vital signs are monitored again.
While amniocentesis is intended to improve pregnancy management, there are potential risks:
• Minimal risk of miscarriage, especially before 15 weeks of pregnancy.
• Rarely, needle injuries to the fetus can occur.
• Cramps and mild vaginal bleeding are possible, as well as amniotic fluid leakage.
• Uterine infections can develop, although this is rare.
• If fetal blood cells enter the mother’s bloodstream, there’s a risk of Rh incompatibility.
Chorionic villus sampling (CVS) is a common alternative, typically performed between 11-14 weeks of pregnancy. It involves using a needle or tube to extract tissue from the placenta and carries a similar level of accuracy to amniocentesis. However, CVS is slightly riskier due to the earlier stage of pregnancy.
Non-invasive testing options, such as second-trimester blood tests and free fetal DNA testing, are also available. These tests, while safer, may not be as definitive as amniocentesis and CVS.
Preparation involves discussing any allergies, medications, or medical history with the doctor. There are generally no specific dietary restrictions before the test. It is important to follow all medical guidance and complete necessary paperwork. Additionally, emptying the bladder may be advised before the procedure.
Amniocentesis boasts an accuracy rate of about 99.4%. In rare cases, results may be inconclusive due to technical issues, such as insufficient fluid collection.
After the procedure, some cramping or mild discomfort is common, and patients may be kept under observation. If discharged the same day, it is important to rest for at least 24 hours and avoid strenuous activity.
If symptoms like heavy vaginal bleeding, fever, severe abdominal pain, or reduced fetal activity occur, medical attention should be sought immediately.
Following the doctor’s advice and instructions is crucial for a smooth recovery.
See how we combine technology and compassion in our care
